Atıf İçin Kopyala
Pierrotti L. C., Perez-Nadales E., Fernandez-Ruiz M., Gutierrez-Gutierrez B., Hock Tan B., Carratala J., ...Daha Fazla
TRANSPLANT INFECTIOUS DISEASE, cilt.23, sa.3, 2021 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
23
Sayı:
3
-
Basım Tarihi:
2021
-
Doi Numarası:
10.1111/tid.13520
-
Dergi Adı:
TRANSPLANT INFECTIOUS DISEASE
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
-
Anahtar Kelimeler:
bloodstream infection, carbapenem‐, sparing regimen, extended‐, spectrum β, ‐, lactamase‐, producing Enterobacterales, kidney transplantation, outcomes, urinary tract infection, BLOOD-STREAM INFECTIONS, PIPERACILLIN-TAZOBACTAM, RISK-FACTORS, ESCHERICHIA-COLI, PNEUMONIAE, MORTALITY, EPIDEMIOLOGY, CARBAPENEMS, RESISTANCE, THERAPY
-
Akdeniz Üniversitesi Adresli:
Evet
Özet
Background Whether active therapy with beta-lactam/beta-lactamase inhibitors (BLBLI) is as affective as carbapenems for extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) bloodstream infection (BSI) secondary to urinary tract infection (UTI) in kidney transplant recipients (KTRs) remains unclear.